Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000454992 | SCV000540120 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 3% in African population, >1% in most other populations. In addition, no clearly associated clinical manifestations |
Invitae | RCV000004214 | SCV000631842 | uncertain significance | Proline dehydrogenase deficiency | 2019-12-26 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with cysteine at codon 453 of the PRODH protein (p.Arg453Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs3970559, ExAC 3%). This variant has previously been reported as a susceptibility allele for hyperprolinemia (PMID: 15494707, 22090377, 24842239). However, this assertion was based on a small study size and other causes of clinical symptoms were not ruled out. ClinVar contains an entry for this variant (Variation ID: 4006). Experimental studies have shown that this missense change reduces POX1 activity (PMID: 15662599). In summary, this variant is a missense change that has been described as a risk factor for hyperprolinemia and has been shown to affect protein function. However, it is very common in the population. For these reasons, it has been classified as a Variant of Uncertain Significance. |
Institute for Genomic Medicine |
RCV000454992 | SCV000864289 | likely benign | not specified | 2017-04-18 | criteria provided, single submitter | clinical testing | BS1, BP6; This alteration has an allele frequency that is greater than expected for the associated disease, and was reported as a benign/likely benign alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory). |
OMIM | RCV000004214 | SCV000024380 | pathogenic | Proline dehydrogenase deficiency | 2005-03-01 | no assertion criteria provided | literature only | |
OMIM | RCV000004215 | SCV000024381 | risk factor | Schizophrenia 4 | 2005-03-01 | no assertion criteria provided | literature only |